CS
Candriam SCA’s Vertex Pharmaceuticals VRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $78.5M | Sell |
176,398
-21,889
| -11% | -$9.75M | 0.45% | 46 |
|
2025
Q1 | $96.1M | Sell |
198,287
-60,335
| -23% | -$29.3M | 0.6% | 29 |
|
2024
Q4 | $104M | Sell |
258,622
-52,685
| -17% | -$21.2M | 0.6% | 29 |
|
2024
Q3 | $145M | Sell |
311,307
-16,964
| -5% | -$7.89M | 0.83% | 22 |
|
2024
Q2 | $154M | Sell |
328,271
-60,317
| -16% | -$28.3M | 0.93% | 17 |
|
2024
Q1 | $162M | Buy |
388,588
+46,502
| +14% | +$19.4M | 1.04% | 17 |
|
2023
Q4 | $139M | Sell |
342,086
-42,245
| -11% | -$17.2M | 0.96% | 18 |
|
2023
Q3 | $134M | Sell |
384,331
-12,231
| -3% | -$4.25M | 0.95% | 16 |
|
2023
Q2 | $140M | Buy |
396,562
+5,654
| +1% | +$1.99M | 1.01% | 15 |
|
2023
Q1 | $113M | Sell |
390,908
-78,237
| -17% | -$22.7M | 0.79% | 19 |
|
2022
Q4 | $135M | Sell |
469,145
-15,394
| -3% | -$4.45M | 0.91% | 15 |
|
2022
Q3 | $140M | Buy |
484,539
+16,656
| +4% | +$4.82M | 0.99% | 14 |
|
2022
Q2 | $132M | Sell |
467,883
-6,370
| -1% | -$1.79M | 1.09% | 13 |
|
2022
Q1 | $124M | Sell |
474,253
-170,379
| -26% | -$44.5M | 0.84% | 22 |
|
2021
Q4 | $142M | Buy |
644,632
+51,803
| +9% | +$11.4M | 0.9% | 18 |
|
2021
Q3 | $108M | Sell |
592,829
-215,038
| -27% | -$39M | 0.73% | 23 |
|
2021
Q2 | $163M | Buy |
807,867
+28,321
| +4% | +$5.71M | 1.12% | 10 |
|
2021
Q1 | $177M | Buy |
779,546
+7
| +0% | +$1.59K | 1.47% | 7 |
|
2020
Q4 | $184M | Buy |
779,539
+221,408
| +40% | +$52.3M | 1.46% | 7 |
|
2020
Q3 | $152M | Buy |
558,131
+11,940
| +2% | +$3.25M | 1.43% | 10 |
|
2020
Q2 | $159M | Sell |
546,191
-179,170
| -25% | -$52M | 1.67% | 6 |
|
2020
Q1 | $155M | Hold |
725,361
| – | – | 1.72% | 7 |
|
2019
Q4 | $159M | Sell |
725,361
-205,638
| -22% | -$45M | 1.7% | 7 |
|
2019
Q3 | $158M | Sell |
930,999
-9,507
| -1% | -$1.61M | 2.09% | 3 |
|
2019
Q2 | $172M | Buy |
940,506
+278,986
| +42% | +$50.9M | 2.14% | 3 |
|
2019
Q1 | $122M | Buy |
661,520
+26,135
| +4% | +$4.81M | 1.56% | 11 |
|
2018
Q4 | $105M | Buy |
635,385
+177,234
| +39% | +$29.4M | 1.62% | 8 |
|
2018
Q3 | $88.3M | Buy |
458,151
+131,345
| +40% | +$25.3M | 1.17% | 11 |
|
2018
Q2 | $55.5M | Buy |
326,806
+23,333
| +8% | +$3.97M | 0.88% | 16 |
|
2018
Q1 | $49.5M | Sell |
303,473
-52,302
| -15% | -$8.52M | 0.84% | 16 |
|
2017
Q4 | $53.3M | Sell |
355,775
-3,087
| -0.9% | -$463K | 0.92% | 13 |
|
2017
Q3 | $54.6M | Buy |
358,862
+85,442
| +31% | +$13M | 0.95% | 14 |
|
2017
Q2 | $35.2M | Buy |
273,420
+40,853
| +18% | +$5.26M | 0.66% | 25 |
|
2017
Q1 | $25.4M | Sell |
232,567
-24,851
| -10% | -$2.72M | 0.49% | 38 |
|
2016
Q4 | $19M | Buy |
257,418
+51,962
| +25% | +$3.83M | 0.44% | 53 |
|
2016
Q3 | $17.9M | Buy |
205,456
+59,226
| +41% | +$5.17M | 0.43% | 58 |
|
2016
Q2 | $12.6M | Sell |
146,230
-11,289
| -7% | -$971K | 0.33% | 78 |
|
2016
Q1 | $12.5M | Sell |
157,519
-85,643
| -35% | -$6.77M | 0.31% | 80 |
|
2015
Q4 | $30.6M | Sell |
243,162
-19,683
| -7% | -$2.48M | 0.82% | 23 |
|
2015
Q3 | $27.4M | Sell |
262,845
-1,009
| -0.4% | -$105K | 0.67% | 25 |
|
2015
Q2 | $32.6M | Buy |
263,854
+42,000
| +19% | +$5.19M | 0.68% | 26 |
|
2015
Q1 | $26.2M | Buy |
221,854
+20,332
| +10% | +$2.4M | 0.53% | 44 |
|
2014
Q4 | $23.9M | Buy |
+201,522
| New | +$23.9M | 0.5% | 55 |
|